Skip to main content
. 2010 Apr 13;28(28):4445–4451. doi: 10.1016/j.vaccine.2010.03.062

Table 3.

The detection of specific serum IgM antibodies to five viruses in the intention-to-treat analysis.

Viruses Experimental group
Control group
χ2 p
Total, N Positive of serum IgM, N (%) Total, N Positive of serum IgM, N (%)
ADV 234 7 (3.0) 240 17 (7.1) 4.127 0.042
RSV 256 2 (0.8) 255 7 (2.8) 1.826 0.177
Flu-A 472 30 (6.4) 460 104 (22.6) 49.988 0.000
Flu-B 519 22 (4.2) 520 84 (16.2) 40.251 0.000
PIV1-3 544 22 (4.0) 545 86 (15.8) 41.971 0.000